In cooperation with our collaboration partner Prof. Andreas Vychytil our abstract "Prospective, Randomized, Multi-Center, Double-Blind, Controlled, Two-Period, Two-Treatment, Crossover, Phase II Trial to Evaluate the Safety and Efficacy of Alanyl-Glutamine in Peritoneal Dialysis" was selected by the International Society of Peritoneal Dialysis council members as the Best Submitted PD Abstract and was presented during the award ceremony at 38th Annual Dialysis Conference. The world largest dialysis conference took place in Orlando, Florida between 3 and 6 March 2018.
zurück zu: cdl-msrpd